By encouraging doctors and scientists to improve the regulation of births through the observation of natural fertility rhythms, Humanae vitae promoted the development of natural family planning (NFP). The study of NFP has lead to NFP-based methodologies in reproductive healthcare that are promoting advances in treatment of infertility, miscarriage, and a number of reproductive health disorders. In contrast, the contraceptive mentality has stunted the development of reproductive healthcare. Humanae vitae has provided a great gift to science and reproductive healthcare that all Catholics should be proud of.
AdashiE.Y., RockJ.A., SappK.C., MartinE.J., WentzA.C., and JonesG.S.1979. Gestational outcome of clomiphene related conception. Fertility and Sterility31: 620–6.
2.
AdashiE.Y., RockJ.A., GuzickD., WentzA.C., JonesG.S., JonesH.W.Jr.1981. Fertility following bilateral ovarian wedge resection: A critical analysis of 90 consecutive cases of polycystic ovary syndrome. Fertility and Sterility36(3): 320–5.
3.
American Academy of Pediatrics and American College of Obstetricians and Gynecologists (AAP and ACOG). 2006. Menstruation in girls and adolescents: Using the menstrual cycle as a vital sign. Pediatrics118(5): 2245–50.
4.
BrinsdenP.R., WadaI., TanS.L., BalenA., and JacobsH.S.1995. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. British Journal of Obstetrics and Gynaecology102(10): 767–72.
5.
CampbellJ.S., PastaD.J., and AdamsonG.D.1995. Preliminary meta-analysis comparing in vitro fertilization with surgical treatment for moderate and severe endometriosis. The Journal of the American Association of Gynecologic Laparoscopists2(4): S6–7.
6.
CarlsonB.2009. Human embryology and developmental biology. 4th ed. Philadelphia: Mosby/Elsevier.
7.
Catechism of the Catholic Church (CCC). 2011. 2nd ed. Vatican City: Libreria Editrice Vaticana.
8.
Centers for Disease Control and Prevention, American Society for Reproductive Medicine, and Society for Assisted Reproductive Technology (CDC et al.). 2011. 2009 Assisted reproductive technology success rates: National summary and fertility clinic reports. Washington, DC: U.S. Department of Health and Human Services.
9.
D'AngeloA.2010. Ovarian hyperstimulation syndrome prevention strategies: Cryopreservation of all embryos. Seminars in Reproductive Medicine28(6): 513–8.
10.
DaniellJ.F., and ChristiansonC.1981. Combined laparoscopic surgery and danazol therapy for pelvic endometriosis. Fertility and Sterility35(5): 521–5.
11.
FitzpatrickE., ReederS.R., and MastroianniL.2009. Maternity nursing. 12th ed. Philadelphia: J. B. Lippincott Company.
12.
GardnerM.O., GoldenbergR.L., CliverS.P., TuckerJ.M., NelsonK.G., and CopperR.L.1995. The origin and outcome of preterm twin pregnancies. Obstetrics and Gynecology85(4): 553–7.
13.
HansenM., KurinczukJ.J., MilneE., de KlerkN., and BowerC.2013. Assisted reproductive technology and birth defects: A systematic review and meta-analysis. Human Reproduction Update19(4): 330–53.
14.
HilgersT.W.2004. The medical & surgical practice of NaProTECHNOLOGY. Omaha: Pope Paul VI Institute Press.
15.
HilgersT.W.2010. The NaProTECHNOLOGY revolution: Unleashing the power in a woman's cycle. New York: Beaufort Books.
16.
Kelley-QuonL.I., TsengC.H., JanzenC., and ShewS.B.2013. Congenital malformations associated with assisted reproductive technology: A California statewide analysis. Journal of Pediatric Surgery48(6): 1218–24.
17.
KimY.J., KuS.Y., JeeB.C., SuhC.S., KimS.H., ChoiY.M., KimJ.G., and MoonS.Y.2010. A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles. Archives of Gynecology and Obstetrics282(2): 199–205.
MooreK.L., PersaudT.V.N., and TorchiaM.G.2013. Before we are born: Essentials of embryology and birth defects. 8th ed. Philadelphia: Elsevier.
21.
MoragianniV.A., and PenziasA.S.2010. Cumulative live-birth rates after assisted reproductive technology. Current Opinion in Obstetrics and Gynecology22(3): 189–92.
22.
OlsonC.K., Keppler-NoreuilK.M., RomittiP.A., BudelierW.T., RyanG., SparksA.E., and Van VoorhisB.J.2005. In vitro fertilization is associated with an increase in major birth defects. Fertility and Sterility84(5): 1308–15.
23.
PaulPopeVI. 1968. Humanae vitae (On the regulation of birth). Vatican City: The Holy See.
ReefhuisJ., HoneinM.A., SchieveL.A., CorreaA., HobbsC.A., RasmmussenS.A., and the National Birth Defects Prevention Study. 2009. Assisted reproductive technology and major structural birth defects in the United States. Human Reproduction24(2): 360–6.
26.
SieglerA.M., and KontopoulosV.1979. An analysis of macrosurgical and microsurgical technique in the management of tuboperitoneal factor in infertility. Fertility and Sterility32(4): 377–83.
27.
SmithJ.E.1988. Humanae vitae: A prophetic document. Washington, DC: United States Conference of Catholic Bishops.
28.
StanfordJ.B., ParnellT.A., and BoyleP.C.2008. Outcomes from treatment of infertility with natural procreative technology in an Irish general practice. Journal of the American Board of Family Medicine21(5): 375–84.
29.
ThamE., SchliepK., and StanfordJ.2012. Natural procreative technology for infertility and recurrent miscarriage: Outcomes in a Canadian family practice. Canadian Family Physician58(5): e267–74.
30.
VitekW.S., GalárragaO., KlatskyP.C., RobinsJ.C., CarsonS.A., and BlazarA.S.2013. Management of the first in vitro fertilization cycle for unexplained infertility: A cost-effectiveness analysis of split in vitro fertilization-intracytoplasmic sperm injection. Fertility and Sterility100(5): 1381–8.
